94 related articles for article (PubMed ID: 3066215)
21. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
[TBL] [Abstract][Full Text] [Related]
22. [Neoadjuvant combined hormonal therapy and radiotherapy with external beam irradiation in prostatic carcinoma].
Cellini N; Luzi S; Morganti AG; Balducci M; Caiazza A; Salvi G; Trodella L; Valentini V
Radiol Med; 1997 Apr; 93(4):446-50. PubMed ID: 9244924
[TBL] [Abstract][Full Text] [Related]
23. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
[TBL] [Abstract][Full Text] [Related]
25. [Clinical investigation of prostate carcinoma in the Third Teaching Hospital of Norman Bethune University of Medical Sciences].
Xiao LS; Niu FR; Xing GJ; Fu YW; Zhao LS; Liu ZY; Znang XP
Hinyokika Kiyo; 1988 May; 34(5):814-8. PubMed ID: 3177123
[TBL] [Abstract][Full Text] [Related]
26. [Update of experience with prostatic cancer].
Nitecki S; Kuten A; Cohen Y
Harefuah; 1993 Mar; 124(5):261-5, 320, 319. PubMed ID: 8495915
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up after triple treatment of prostate cancer stage pT3.
Schelin S; Madsen M; Palmqvist E; Mäkelä E; Klintenberg C; Aus G
Scand J Urol Nephrol; 2009; 43(3):186-91. PubMed ID: 19353383
[TBL] [Abstract][Full Text] [Related]
28. [Clinical analysis and treatment of carcinoma of the prostate with bone metastasis].
Kawai T; Washizuka M; Yamauchi T; Ishibashi Y; Sumi S; Kokuho M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1704-9. PubMed ID: 3592710
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
Grande M; Carlström K; Rozell BL; Stege R; Pousette A
Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
[TBL] [Abstract][Full Text] [Related]
30. Retrospective study on stage B prostate cancer in the Hokuriku District, Japan.
Egawa M; Misaki T; Imao T; Yokoyama O; Fuse H; Suzuki K; Namiki M
Int J Urol; 2004 May; 11(5):304-9. PubMed ID: 15147546
[TBL] [Abstract][Full Text] [Related]
31. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
Lawton CA; Winter K; Grignon D; Pilepich MV
J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
[TBL] [Abstract][Full Text] [Related]
32. The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.
Stone NN; Stock RG
J Urol; 2007 Mar; 177(3):925-8. PubMed ID: 17296377
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors in patients with prostatic cancer treated with neoadjuvant hormonal therapy and radical prostatectomy].
Villavicencio Mavrich H; Chéchile Toniolo G; Salinas Duffo D; Muñoz Plaza J; Sorraca Ibáñez YJ
Arch Esp Urol; 1996 Oct; 49(8):797-806. PubMed ID: 9065276
[TBL] [Abstract][Full Text] [Related]
34. Failure to achieve a PSA level Mitchell DM; McAleese J; Park RM; Stewart DP; Stranex S; Eakin RL; Houston RF; O'Sullivan JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1467-71. PubMed ID: 17689886
[TBL] [Abstract][Full Text] [Related]
35. Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: a 20-year followup.
Porter MP; Ahaghotu CA; Loening SA; See WA
J Urol; 1997 Oct; 158(4):1466-9. PubMed ID: 9302144
[TBL] [Abstract][Full Text] [Related]
36. [Determination of prognostic factors in incidental prostatic carcinoma].
Caicedo Caicedo PS; Chéchile Toniolo G; Featherston Medvedoff M; Sanchotene Cardozo E; Ortiz Azuero A; Ferro Medina E; Segarra Tomas J; Villavicencio Mavrich H; Vicente Rodríguez J; Algaba Arrea F
Arch Esp Urol; 1993 Dec; 46(10):868-74. PubMed ID: 7511366
[TBL] [Abstract][Full Text] [Related]
37. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
[TBL] [Abstract][Full Text] [Related]
38. [Prostatic cancer in a young adult: a report of 2 cases].
Sasaki H; Miki J; Hasegawa T; Hasegawa N; Ikemoto I; Ohishi Y
Hinyokika Kiyo; 2004 Jan; 50(1):57-9. PubMed ID: 15032019
[TBL] [Abstract][Full Text] [Related]
39. Should we treat localized prostate cancer? An opinion.
Menon M; Parulkar BG; Baker S
Urology; 1995 Nov; 46(5):607-16. PubMed ID: 7495109
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan.
Sasaki T; Nakamura K; Ogawa K; Onishi H; Okamoto A; Koizumi M; Shioyama Y; Mitsumori M; Teshima T;
BJU Int; 2009 Nov; 104(10):1462-6. PubMed ID: 19522869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]